相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treating NAFLD in OLETF Rats with Vigorous-Intensity Interval Exercise Training
Melissa A. Linden et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2015)
Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway
Young Mi Song et al.
AUTOPHAGY (2015)
Rapamycin and Dietary Restriction Induce Metabolically Distinctive Changes in Mouse Liver
Zhen Yu et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2015)
Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats
Melissa A. Linden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Sayaka Inokuchi-Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age?
Gabor Firneisz
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatic steatosis development with four weeks of physical inactivity in previously active, hyperphagic OLETF rats
Melissa A. Linden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation
Graeme J. Gowans et al.
CELL METABOLISM (2013)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
Connecting mTORC1 signaling to SREBP-1 activation
Inan Bakan et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Independent and Combined Effects of Exercise Training and Metformin on Insulin Sensitivity in Individuals With Prediabetes
Steven K. Malin et al.
DIABETES CARE (2012)
Nonalcoholic Fatty Liver Disease/Steatohepatitis: Epidemiology, Pathogenesis, Clinical Presentation and Treatment
Sandra Milic et al.
DIGESTIVE DISEASES (2012)
The Role of Metformin in the Management of NAFLD
Angela Mazza et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Christian Thoma et al.
JOURNAL OF HEPATOLOGY (2012)
BNip3 Regulates Mitochondrial Function and Lipid Metabolism in the Liver
Danielle Glick et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model
R. Scott Rector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
The serine/threonine kinase ULK1 is a target of multiple phosphorylation events
Markus Bach et al.
BIOCHEMICAL JOURNAL (2011)
Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover
S. Rikka et al.
CELL DEATH AND DIFFERENTIATION (2011)
Metformin Inhibits Nuclear Receptor TR4-Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity
Eungseok Kim et al.
DIABETES (2011)
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
Maria Eugenia Miquilena-Colina et al.
GUT (2011)
Does physical inactivity cause nonalcoholic fatty liver disease?
R. Scott Rector et al.
JOURNAL OF APPLIED PHYSIOLOGY (2011)
Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats
R. Scott Rector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage
Partha Chakrabarti et al.
DIABETES (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model
R. Scott Rector et al.
JOURNAL OF HEPATOLOGY (2010)
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease
Maria Cristina Elias et al.
NUTRITION (2010)
Effects of Metformin and Weight Loss on Serum Alanine Aminotransferase Activity in the Diabetes Prevention Program
Jonathan Krakoff et al.
OBESITY (2010)
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
R. Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
Nathalie C. Leite et al.
LIVER INTERNATIONAL (2009)
Nonalcoholic Hepatic Steatosis in Zucker Diabetic Rats: Spontaneous Evolution and Effects of Metformin and Fenofibrate
Fabien Forcheron et al.
OBESITY (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats
R. Scott Rector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes
Takayuki Matsumoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats
R. Scott Rector et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function
D. Enette Larson-Meyer et al.
OBESITY (2008)
Non-alcoholic fatty liver disease and the metabolic syndrome: An update
R. Scott Rector et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
Claudia Pinto Marques Souza de Oliveira et al.
HEPATOLOGY RESEARCH (2008)
Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes
Rita Basu et al.
DIABETES (2008)
Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis
Ning-Chun Liu et al.
DIABETES (2007)
Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: Developmental aspects
Timothy H. Moran et al.
DEVELOPMENTAL PSYCHOBIOLOGY (2006)
Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans
MW Hulver et al.
CELL METABOLISM (2005)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
E Bugianesi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes -: A randomized controlled study
HKR Karlsson et al.
DIABETES (2005)
Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver
P Dobrzyn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Metformin in the treatment of patients with non-alcoholic steatohepatitis
A Uygun et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
Metformin treatment enhances insulin-stimulated glucose transport in skeletal muscle of Sprague-Dawley rats
SE Borst et al.
LIFE SCIENCES (2000)
Metformin reverses fatty liver disease in obese, leptin-deficient mice
HZ Lin et al.
NATURE MEDICINE (2000)
分享论文
